Sensus Healthcare Q1 Earnings Call Highlights
Sensus Healthcare NASDAQ: SRTS said its first quarter of 2026 marked a transition period as new dedicated CPT codes for superficial radiotherapy took effect, while revenue declined from the prior year due largely to the absence of sales to its historically largest customer.
Sensus Healthcare, Inc. (SRTS) Q1 2026 Earnings Call Transcript
Sensus Healthcare, Inc. (SRTS) Q1 2026 Earnings Call Transcript
Sensus Healthcare, Inc. (SRTS) Q4 2025 Earnings Call Transcript
Sensus Healthcare, Inc. (SRTS) Q4 2025 Earnings Call Transcript
Sensus Healthcare, Inc. (SRTS) Q3 2025 Earnings Call Transcript
Sensus Healthcare, Inc. ( SRTS ) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Joseph Sardano - Co-Founder, Chairman & CEO Michael Sardano - President, General Counsel, Corporate Secretary & Director Javier Rampolla - Chief Financial Officer Conference Call Participants Tirth Patel - Lippert/Heilshorn & Associates, Inc. Anthony Vendetti - Maxim Group LLC, Research Division Benjamin Haynor - Lake Street Capital Markets, LLC, Research Division Eduardo Martinez-Montes - H.C. Wainwright & Co, LLC, Research Division Presentation Operator Good day, and welcome to the Sensus Healthcare Third Quarter 2025 Financial Results Conference Call.
Sensus Healthcare, Inc. (SRTS) Falls More Steeply Than Broader Market: What Investors Need to Know
Sensus Healthcare, Inc. (SRTS) closed the most recent trading day at $3.31, moving 4.06% from the previous trading session.
Sensus Healthcare, Inc. (SRTS) Outperforms Broader Market: What You Need to Know
The latest trading day saw Sensus Healthcare, Inc. (SRTS) settling at $3.15, representing a +1.29% change from its previous close.
Is Sensus Healthcare (SRTS) a Buy as Wall Street Analysts Look Optimistic?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Sensus Healthcare, Inc. (SRTS) Q2 2025 Earnings Call Transcript
Sensus Healthcare, Inc. (NASDAQ:SRTS ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Javier Rampolla - Chief Financial Officer Joseph C. Sardano - Co-Founder, Chairman & CEO Michael J.
Sensus Healthcare, Inc. (SRTS) Reports Q2 Loss, Misses Revenue Estimates
Sensus Healthcare, Inc. (SRTS) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of $0.01. This compares to earnings of $0.1 per share a year ago.
Sensus Healthcare, Inc. (SRTS) Stock Drops Despite Market Gains: Important Facts to Note
In the most recent trading session, Sensus Healthcare, Inc. (SRTS) closed at $5.51, indicating a -2.48% shift from the previous trading day.
Why Sensus Healthcare, Inc. (SRTS) Outpaced the Stock Market Today
Sensus Healthcare, Inc. (SRTS) reached $4.44 at the closing of the latest trading day, reflecting a +2.54% change compared to its last close.
Sensus Healthcare, Inc. (SRTS) Declines More Than Market: Some Information for Investors
Sensus Healthcare, Inc. (SRTS) closed at $4.64 in the latest trading session, marking a -2.11% move from the prior day.
